Detection of diversity of fetal heart function in pregnancy-induced hypertension patients by ultrasonography in Aljouf Region, Saudi Arabia.

Background: The common pregnancy illness known as pregnancy-induced hypertension syndrome (PIH) has the potential to harm both the mother's and the fetus' organs to varying degrees. An essential tool for assessing fetal heart function is ultrasound.

Objective: The goal of this study is to use ultrasound to measure the variety of fetal heart function in patients with pregnancy-induced hypertension.

Material and methods: This hospital-based retrospective study was carried out between January 2021 and January 2022 at the Obstetric Department of Maternity and Children Hospital (MCH), Sakaka, Aljouf, Saudi Arabia, to assess the changes in fetal cardiac function in patients with pregnancy-induced hypertension compared to healthy pregnant women in general. The research process involved screening 60 pregnant women for pregnancy-induced hypertension (PIH) and 40 healthy pregnant women for the control group. Each of the 100 pregnant women had a single fetus, and no prenatal abnormalities were found. All eligible patients underwent prenatal ultrasounds in order to collect the cardiac function measures needed to assess the variety of fetal heart functions rapidly and effectively.

Results: When compared to healthy pregnant women, the results of the ultrasound show a higher significance of the fetal thickness of the cardiac septum, left and right ventricular end-systolic and end-diastolic perimeter and area. Additionally, our ultrasonography findings demonstrate that fetal ventricular systolic fractions 1 and 2 (VSF1 and VSF2) were more significant in patients with pregnancy-induced hypertension (PIH) compared to healthy pregnant women in general.

Conclusion: The cardiac functions of the fetus are negatively affected by pregnancy-induced hypertension (PIH).